Skip to Content

Rule

New Animal Drugs; Change of Sponsor

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration

ACTION:

Final rule.

SUMMARY:

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the change of sponsor for 25 approved new animal drug applications (NADA's) from Merial Ltd. to Bimeda, Inc.

DATES:

This rule is effective March 9, 2001.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Norman J. Turner, Center for Veterinary Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0214.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Merial Ltd., 2100 Ronson Rd., Iselin, NJ 08830-3077, has informed FDA that it has transferred ownership of, and all rights and interests in, the following approved NADA's to Bimeda, Inc., 288 County Rd. 28, LeSueur, MN 56058-9322.

Accordingly, the agency is amending the regulations in 21 CFR parts 510, 520, 522, 524, 526, and 558 to reflect the change of sponsor. The agency is also amending § 510.60(c)(1) and (c)(2) to add the sponsor name and drug labeler code for Bimeda, Inc.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

Start List of Subjects

List of Subjects

End List of Subjects

21 CFR Parts 520, 522, 524, and 526

Animal drugs.

21 CFR Part 558

Animal drugs, Animal feeds.

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, 522, 524, 526, and 558 are amended as follows:

Start Part Start Printed Page 14073

PART 510—NEW ANIMAL DRUGS

1. The authority citation for 21 CFR part 510 continues to read as follows:

Start Authority

Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

End Authority

2. Section 510.600 is amended in the table in paragraph (c)(1) by alphabetically adding an entry for “Bimeda, Inc.” and in the table in paragraph (c)(2) by numerically adding an entry for “061133” to read as follows:

Names, addresses, and drug labeler codes of sponsors of approved applications.
* * * * *

(c) * * *

(1) * * *

Firm name and addressDrug labeler code
 *          *          *          *          *          *          *  
Bimeda, Inc., 288 County Rd. 28, LeSueur, MN 56058-9322061133
 *          *          *          *          *          *          *  

(2) * * *

Drug labeler codeFirm name and address
 *          *          *          *          *          *          *  
061133Bimeda, Inc., 288 County Rd. 28, LeSueur, MN 56058-9322
 *          *          *          *          *          *          *  
End Part Start Part

PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS

3. The authority citation for 21 CFR part 520 continues to read as follows:

Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]

4. Section 520.390a Chloramphenicol tablets is amended in paragraph (b)(2) by removing “050604” and by adding in its place “061133”.

[Amended]

5. Section 520.540b Dexamethasone tablets and boluses is amended in paragraph (b)(2) by removing “050604” and by adding in its place “061133”.

[Amended]

6. Section 520.622a Diethylcarbamazine citrate tablets is amended in paragraph (a)(3) by removing “050604” and by adding in its place “061133”.

[Amended]

7. Section 520.622c Diethylcarbamazine citrate chewable tablets is amended in paragraph (b)(4) by removing “050604” and by adding in its place “061133”.

[Amended]

8. Section 522.823 Erythromycin phosphate is amended in paragraph (b) by removing “050604” and by adding in its place “061133”.

[Amended]

9. Section 520.1484 Neomycin sulfate soluble powder is amended in paragraph (b) by removing “050604, and” and by adding “, and 061133” after “051259”.

[Amended]

10. Section 520.1660d Oxytetracycline hydrochloride soluble powder is amended in paragraph (b)(7) by removing “050604” and by adding in its place “061133”.

[Amended]

11. Section 520.1696b Penicillin G potassium in drinking water is amended in paragraph (b) by removing “050604, and” and by adding “, and 061133” after “053501”.

[Amended]

12. Section 520.1720a Phenylbutazone tablets and boluses is amended in paragraph (b)(3) by removing “and 059130” and by adding in its place “059130, and 061133”.

[Amended]

13. Section 520.1720d Phenylbutazone gel is amended in paragraph (b) by removing “050604” and by adding in its place “061133”.

[Amended]

14. Section 520.2123a Spectinomycin dihydrochloride pentahydrate tablets is amended in paragraph (b), by removing “050604” and by adding in its place “061133”.

[Amended]

15. Section 520.2123b Spectinomycin dihydrochloride pentahydrate soluble powder is amended in paragraph (b) by removing “050604” and by adding in its place “061133”.

[Amended]

16. Section 520.2260b Sulfamethazine sustained-release boluses is amended in paragraphs (c)(1) and (e)(1) by removing “050604” and by adding in its place “061133”.

End Part Start Part

PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS

17. The authority citation for 21 CFR part 522 continues to read as follows:

Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]

18. Section 522.820 Erythromycin injection is amended in paragraph (a) by removing “050604” and by adding its place “061133”.

[Amended]

19. Section 522.2444b Sodium thiopental, sodium pentobarbital for injection is amended in paragraph (b) by removing “050604” and by adding in its place “061133”.

End Part Start Part Start Printed Page 14074

PART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS

20. The authority citation for 21 CFR part 524 continues to read as follows:

Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]

21. Section 524.1580b Nitrofurazone ointment is amended in paragraph (b) by removing “and 051259” and by adding in its place “051259, and 061133”.

End Part Start Part

PART 526—INTRAMAMMARY DOSAGE FORMS

22. The authority citation for 21 CFR part 526 continues to read as follows:

Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]

23. Section 526.820 Erythromycin is amended in paragraph (b) by removing “050604” and by adding in its place “061133”.

End Part Start Part

PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

24. The authority citation for 21 CFR part 558 continues to read as follows:

Start Authority

Authority: 21 U.S.C. 360b, 371.

End Authority
[Amended]

25. Section 558.58 Amprolium and ethopabate is amended in the table in paragraph (d)(1), in item (iii), for the entry “Arsanilic acid 90 (0.01 pct) plus erythromycin 4.6 to 18.5”, under the “Sponsor” column by adding “061133”.

26. Section 558.62 is amended by revising paragraph (a)(1), by adding paragraph (a)(3), and in the table in paragraph (c)(1) by redesignating entries (c)(1)(iii), (c)(1)(iv), and (c)(1)(v) as entries (c)(1)(iv), (c)(1)(vi), and (c)(1)(vii), respectively, and by adding new entries (c)(1)(iii) and (c)(1)(v) to read as follows:

Arsanilic acid.

(a) * * *

(1) To 015565: 20, 50, and 100 percent for use as in the table in paragraph (c)(1), entry (ii), item 1; entry (ii), item 2; entry (iv); entry (vi); and entry (vii) of this section.

*  *  *  *  *

(3) To 061133: 90 grams per pound arsanilic acid and 4.6 grams per pound erythromycin equivalents as erythromycin thiocyanate for use as in paragraph (c)(1), entry (iii); 90 grams per pound arsanilic acid and 9.25 grams per pound erythromycin equivalents as erythromycin thiocyanate for use as in paragraph (c)(1), entry (v).

*  *  *  *  *

(c) * * *

(1) * * *

Arsanilic acid in grams per tonCombination in grams per tonIndications for useLimitationsSponsor
 *          *          *          *          *          *          *  
(iii)Erythromycin 4.6Chickens; growth promotion and feed efficiency; improving pigmentation.As erythromycin thiocyanate; withdraw 5 days before slaughter; as sole source of organic arsenic.     012487
 *          *          *          *          *          *          *  
(v)Erythromycin 9.25Chickens; growth promotion and feed efficiency; improving pigmentation.As erythromycin thiocyanate; withdraw 5 days before slaughter; as sole source of organic arsenic.     012487
 *          *          *          *          *          *          *  

*  *  *  *  *

[Amended]

27. Section 558.248 Erythromycin thiocyanate is amended in paragraphs (a)(1) and (a)(2) by removing “050604” and by adding in its place “061133”, and in the table in paragraph (d)(1), in entries (i) through (vi), under the “Sponsor” column by removing “050604” wherever it appears and by adding in its place “061133”.

[Amended]

28. Section 558.625 Tylosin is amended in paragraph (b)(39) by removing “50604” and by adding in its place “061133”.

Start Signature

Dated: January 29, 2001

Claire M. Lathers,

Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

End Signature End Part End Supplemental Information

[FR Doc. 01-5680 Filed 3-8-01; 8:45 am]

BILLING CODE 4160-01-F